Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs iShares Semiconductor ETF — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while iShares Semiconductor ETF trades at $506 (market cap $42.65B). The key difference: iShares Semiconductor ETF is far larger — about 4.8× Kymera Therapeutics Inc. Common Stock's market cap, and iShares Semiconductor ETF is more actively traded (10,736,485 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and iShares Semiconductor ETF for 47 Days on average.
| KYMR | SOXX | |
|---|---|---|
Market Cap | $8.88B | $42.65B |
Volume | 1,028,790 | 10,736,485 |
Sector | Health | Sector/Thematic |
52-Week High | $127.31 | $655.01 |
52-Week Low | $55.80 | $268.10 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $8.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXX trades at $543.9, down 0.17% with a bearish technical signal. The ETF faces mixed sentiment as AI-driven semiconductor demand fuels optimism, but high valuations and Michael Burry's short positions highlight risks. Recent news shows strong September performance (+11%) and positive earnings revisions, though technical indicators suggest near-term pressure with support at $531.
Outlook hinges on AI infrastructure growth, with BofA projecting the semiconductor market to nearly double by 2030. Risks include valuation concerns (P/E of 68.79 per Seeking Alpha), concentration in top holdings, and macroeconomic volatility. Earnings growth remains a key catalyst, but investors should weigh high multiples against sector momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
